Vertex Announces Progress In Povetacicept Development Program And Presentation Of New Data At American Society Of Nephrology Kidney Week
Refinitiv閱讀少於1分鐘
Vertex Pharmaceuticals Inc VRTX:
VERTEX ANNOUNCES PROGRESS IN POVETACICEPT DEVELOPMENT PROGRAM AND PRESENTATION OF NEW DATA AT AMERICAN SOCIETY OF NEPHROLOGY KIDNEY WEEK
VERTEX PHARMACEUTICALS INC - FDA GRANTS ROLLING REVIEW FOR POVETACICEPT IN IGA NEPHROPATHY
VERTEX PHARMACEUTICALS INC: EXPECTS TO SUBMIT FIRST MODULE TO FDA FOR POTENTIAL ACCELERATED APPROVAL BEFORE END OF 2025
VERTEX PHARMACEUTICALS INC: REMAINS ON TRACK TO COMPLETE FULL BLA SUBMISSION FOR ACCELERATED APPROVAL IN U.S. IN FIRST HALF OF 2026
登入或建立一個永久免費帳戶來閱讀此新聞